Hayat Pharmaceutical Industries Co. PLC (ASE: HPIC)
Health Care · Pharmaceuticals · JO
JD3.17
-0.63% today · +5.3% 1Y
Hayat Pharmaceutical Industries Co. PLC (ASE: HPIC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.48M.
Over the last twelve months the share price has gained 5.3%, trading between 2.98 and 3.55.
Tweenvest scores Hayat Pharmaceutical Industries Co. PLC across four factors: quality 87/100, value 21/100, dividend 90/100. Its strongest factor is dividend.
HPIC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.48M
- Revenue (TTM)
- $24.54M
- P/E
- 12.93
- EPS
- 0.25
- Dividend yield
- 5.99%
- Beta (5Y)
- 0.09
- 52-week high
- JD3.55
- 52-week low
- JD2.98
- Avg volume (3M)
- —
- Shares outstanding
- 9.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Decibel Cannabis Company Inc.TSXV: DB | $43.14M | CA$1.60 | -4.76% |
| Jenburkt Pharmaceuticals LimitedBSE: 524731 | $43.09M | Rs945.00 | +2.12% |
| Sofgen Pharma S.A.OTCPK: PROC.F | $43.07M | $— | — |
| Medicamen Biotech LimitedBSE: 531146 | $42.79M | Rs305.35 | -3.16% |
| Tsubota Laboratory IncorporatedTSE: 4890 | $42.35M | ¥260.00 | +3.59% |
| Veru Inc.NasdaqCM: VERU | $41.94M | $2.41 | -2.24% |
| Orion Infusion LimitedDSE: ORIONINFU | $41.46M | Tk250.80 | -2.68% |
| Enzymatica AB (publ)OM: ENZY | $41.39M | Skr1.77 | +3.81% |
Figures last refreshed Oct 11, 2026.